Arkolith/Insider Trading/FNCH/Form 4

Smisek Jeffery A

DirectorFinch Therapeutics Group, Inc. (FNCH) · full profile →Form 4 · filed Mar 29, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$21K
Net Open-Market Flow
-$21K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 28, 2024Sell(S)7K$2.57$17K0
Mar 28, 2024Sell(S)2K$2.61$4K7K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-038657) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML